ABSTRACT:
Human Immunodeficiency Virus (HIV) is the cause of AIDS (Acquired immune deficiency syndrome). HIV impairs the immune system and interferes with the body's ability to fight off disease and disorder. Contact with contaminated blood, semen or vaginal secretions is how it spreads. Although there is no known cure, medications can control the infection and stop the disease from getting worse. The nucleoside reverse transcriptase inhibitor (NRTI) counterpart of guanosine, abacavir, is sold as abacavir sulphate. This substance lowers HIV viral loads and delays or prevents immune system from damage. This succinct analysis of abacavir exemplifies the discussion of analytical techniques used to investigate abacavir in bulk and different dosage forms such as UV spectroscopy, HPLC, HPTLC, UPLC, and LC-MS. This helps the researcher who is willing to work on this drug or on multidrug combinations including abacavir. They will get detailed information about the method development and validation of the same by ICH guidelines. This comprehensive evaluation takes a look at analytical methods that were published between 2008 and 2018 using different analytical techniques.
Cite this article:
Ramgopal M Dhanwad, Pavitra R. Basannavar, Vishakha Saraf. A Review on Analytical Methods for Estimation of Abacavir. Research Journal of Pharmacy and Technology. 2025;18(10):5047-3. doi: 10.52711/0974-360X.2025.00729
Cite(Electronic):
Ramgopal M Dhanwad, Pavitra R. Basannavar, Vishakha Saraf. A Review on Analytical Methods for Estimation of Abacavir. Research Journal of Pharmacy and Technology. 2025;18(10):5047-3. doi: 10.52711/0974-360X.2025.00729 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2025-18-10-68
REFERENCES:
1. Carr A. HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS. 2003; Apr;17 Suppl1:S141-8.
2. S. Janet Beula, T. Ramamohan Reddy, R. Suthakaran, M. Viswaja. RP-HPLC Method Development and Validation for the Estimation of Lafutidine using Bulk and Pharmaceutical Dosage Forms. Research Journal of Pharmaceutical Dosage Forms and Technology. 2023; 15(3): 184-8.
3. www.drugbank.ca, http://go.drugbank.com/drugs/DBO1048
4. Raju NA, Rao JV, Prakash KV, Mukkanti K. Spectrophotometric estimation of abacavir sulphate in pharmaceutical formulations. E-Journal of Chemistry. 2008; Jul 1; 5(3): 511-4.
5. Supritha HR. Analytical Method Development and Validation of Abacavir in Pure and Pharmaceutical Dosage Forms by Using UV-Spectrophotometric Method. World Journal of Pharmaceutical Sciences. 2018; Feb 1: 74-8.
6. Nagulwar VP, Bhusari KP. Simultaneous estimation of Abacavir, Lamivudine and Zidovudine in combined tablet dosage form by UV spectrophotometric method. Int J Res Ayurveda and Pharm. 2011; 2: 610-4.
7. Akhilesh S. Tokey, Mugdha R. Suryawanshi, Pranav P. Tambe. Development And Validation OfUv Spectroscopic Method For Estimation Of Abacavir In Tablet Dosage Form. International Journal Of Current Pharmaceutical Research. 2022; 14(5): 36-39.
8. B Ranjita, S Prashanti, K Ram Shuba Reddy, S K Gulati, G Tuljarani. New colorimetric methods for the estimation of abacavir sulphate in bulk and dosage forms.International Journal of Chemical Sciences. 2011; 9(1): 205-213
9. Pavan Kumar, D., Naga Jhansi, T., Srinivasa Rao, G. and Kirti Kumar Jain. A validated SP-HPLE method for abacavir sulphate. International Journal of Current Research. 2018; 1(12): 76072-76076
10. Ahmad SA, Patil L, Usman MR, Imran M, Akhtar R. Analytical method development and validation for the simultaneous estimation of abacavir and lamivudine by reversed-phase high-performance liquid chromatography in bulk and tablet dosage forms. Pharmacognosy Research. 2018; 10(1): 92.
11. Pal N, Rao AS, Ravikumar P. Simultaneous HPLC method development and validation for estimation of Lamivudine, Abacavir and Dolutegravir in combined dosage form with their stability studies. Asian Journal of Chemistry. 2016; 28(2): 273.
12. Sudha T, Ravikumar VR, Hemalatha PV. Validated HPTLC method for simultaneous determination of lamivudine and abacavir sulphate in tablet dosage form. International Journal of Pharmaceutical Sciences and Research. 2010; 1(11): 107.
13. A Bekhit A, Alemayehu A, I Mohamed AM, Hymete A. HPTLC-densitometry method development and validation for simultaneous determination of abacavir, lamivudine and zidovudine in combined dosage form. Journal of the Iranian Chemical Research. 2011; 4(4): 251-62.
14. Kadivendi Chandrika, V Chaithanya. RP-HPLC Method Development and Validation for the Estimation of Abacavir and Lamivudine. Ijsrm.Human. 2020; 15 (1): 97-109.
15. Yadav M, Gupta A, Singhal P, Shrivastav PS. Development and validation of a selective and rapid LC-MS-MS method for the quantification of abacavir in human plasma. J Chromatogr Sci. 2010; 48(8): 654-62. doi: 10.1093/chromsci/48.8.654. PMID: 20819295.
16. Dubey S, Duggirala M. Simultaneous estimation of lamivudine, abacavir and dolutegravir by UPLC method. Int. J. App. Pharm. 2018; 10(1): 46-52.
17. L. Satyanarayana, S.V. Naidu, M. Narasimha Rao, C. Ayyanna, Alok Kumar. The Estimation of Raltigravir in Tablet dosage form by RP-HPLC. Asian J. Pharm. Ana. 2011; 1(3): 56-58.
18. Jitendra Verma, Dheeraj Jain, Nilesh Jain, Sharad P Pandey, Deepak Kumar Jain. Simultaneous Estimation of Lamivudine, Stavudine and Nevirapine by RP-HPLC in Tablet Formulation. Research J. Pharm. and Tech. 2010; 3(2): 490-493.
19. Prasada Rao CH , Seshagiri Rao JVLN, Dhachinamoorthi D, Lakshmi Aswini G, Ashok K. Visible Spectrophotometric Determination of Abacavir Sulphate in Bulk Drug and Tablet Dosage Form. Research J. Pharm. and Tech. 2011; 4(2): 234-236.
20. T. Sudha, P. Shanmugasundram. Development and Validation of RP-HPLC and HPTLC Chromatographic Methods of Analysis for the Quantitative Estimation of Raltegravir Potassium in Pharmaceutical Dosage Form. Research J. Pharm. and Tech. 2011; 4(11): 1746-1750.
21. Ganesh Shinde, Godage R. K, Dr R. S. Jadhav, Barhate Manoj, Bhagwat Aniket. A Review on Advances in UV Spectroscopy. Research J. Science and Tech. 2020; 12(1): 47-51.
22. Suvarna. S. Dhone, Jyoti D. Anap, Nalawade Dipak D., Kote Prasad C.. A Review on Moxifloxacin. Research Journal of Science and Technology. 2023; 15(3): 161-4.
23. Dipak Nalawade, R. K. Godge, S. D. Magar. Analytical Method Development and Validation of Ritonavir: A Review. Research J. Science and Tech. 2020; 12(2): 157-162.
24. Sri Lakshmi D, Jane T Jacob, Srinivasa Sastry D, Satyanarayana D. Simultaneous Estimation of Metformin Glimeperide and Voglibose by RP-UPLC. Asian J. Pharm. Ana. 2017; 7(1): 23-30.
25. Hamid Khan, Javed Ali. UHPLC: Applications in Pharmaceutical Analysis. Asian J. Pharm. Ana. 2017; 7(2): 124-131.
26. Rohini S. Koli, Aslam S. Patel, Kamlesh N. Chaudhari, Khushbu R. Patil. A Review on HPLC and Its New Trends. Asian J. Pharm. Ana. 2018; 8(4): 233-236.
27. Hamid Khan. Identification and Characterization of Degradation Products of Valsartan by UPLC/Q-TOF-MS Technique. Asian J. Pharm. Res. 2021; 11(1): 1-5.
28. H. S. Jumde, S. D. Mankar. Review on development of Analytical Method and Validation by Reverse Phase – High Performance Liquid Chromatography. Asian Journal of Pharmacy and Technology. 2022; 12(2): 179-2.
29. Mirza Shahed, Palaskar Pallavi S, MHG Dehghan, SN Mokale. Simultaneous Spectrophotometric Estimation of Abacavir sulfate and Lamivudine in Tablet Dosage Form. Asian J. Research Chem. 2009; 2(4): 461-463.
30. V.P. Devmurari. Simultaneous Spectrophotometric Determination of Lamivudine and Abacavir in the Mixture. Asian J. Research Chem. 2010; 3(3): 707-709.